Open Access Highly Accessed Email this article to a friend

A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer

Mitchell Gross*, Celestia Higano, Allan Pantuck, Olga Castellanos, Erica Green, Koo Nguyen and David B Agus

BMC Cancer 2007, 7:142  doi:10.1186/1471-2407-7-142

Fields marked * are required

Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Cancer's emails?